Cite
HARVARD Citation
Gagliardini, R. et al. (2018). 3-Year Efficacy and Durability of Simplification to Single Tablet Regimens: A Comparison between Co-Formulated Efavirenz/Emtricitabine/Tenofovir and Rilpivirine/Emtricitabine/Tenofovir. Antiviral therapy. 23 (2), pp. 139-148. [Online].